News | August 26, 2022
JB Pharma ranks 23 in Indian pharma market
JB Pharma is the fastest growing pharmaceutical company in FY 2021-22 and Q1 of FY 2022-23.
JB Pharma is the fastest growing pharmaceutical company in FY 2021-22 and Q1 of FY 2022-23.
3D CMOS chip for connecting electroactive tissues and organoids to software
The CSC shall hold Market Authorisation (MA) to sell SRL's BUSALFAN, API exclusively in China territory.
The Velcade Brand and generic had U.S. sales of approximately $1.2 billion MAT for the most recent twelve months ending in May 2022
The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
Govt committed to supporting pharma companies with industry-friendly policies
Subscribe To Our Newsletter & Stay Updated
